APA (7th ed.) Citation

Pei, K., Xu, H., Wang, P., Gan, W., Hu, Z., Su, X., . . . He, Y. (2023). Anti‐CLL1‐based CAR T‐cells with 4‐1‐BB or CD28/CD27 stimulatory domains in treating childhood refractory/relapsed acute myeloid leukemia. Cancer Medicine, 12(8), 9655. https://doi.org/10.1002/cam4.5916

Chicago Style (17th ed.) Citation

Pei, Kunlin, Haoyu Xu, Pengfei Wang, Wening Gan, Zhengbin Hu, Xiaoling Su, Hui Zhang, and Yingyi He. "Anti‐CLL1‐based CAR T‐cells with 4‐1‐BB or CD28/CD27 Stimulatory Domains in Treating Childhood Refractory/relapsed Acute Myeloid Leukemia." Cancer Medicine 12, no. 8 (2023): 9655. https://doi.org/10.1002/cam4.5916.

MLA (9th ed.) Citation

Pei, Kunlin, et al. "Anti‐CLL1‐based CAR T‐cells with 4‐1‐BB or CD28/CD27 Stimulatory Domains in Treating Childhood Refractory/relapsed Acute Myeloid Leukemia." Cancer Medicine, vol. 12, no. 8, 2023, p. 9655, https://doi.org/10.1002/cam4.5916.